Navigation Links
Viral replicase points to potential cancer therapy
Date:3/27/2011

Alpha viruses, such as Sindbis virus, carry their genetic information on a single strand of RNA. On infection they use a protein, replicase, to produce double stranded RNA (dsRNA) which is used as genetic material to make more viruses. However the body recognizes dsRNA as foreign, and infected cells initiate an immune response. New research published in BioMed Central's open access journal BMC Cancer demonstrates that an artificial plasmid coding for the replicase genes of Sindbis virus causes regression and destruction of lung cancer, or melanoma, cells in mice.

Previous attempts to use synthetic dsRNA to destroy tumor cells have met with problems, including side effects at an effective dose, but there are also concerns about using attenuated viruses, to deliver dsRNA inside cells. Researchers from the University of Texas at Austin have instead used a plasmid containing Sindbis replicase genes (nsp1-4) to force cells to produce dsRNA themselves.

For ten days mice were given daily injections of plasmid into the site of a tumor. After another 15 days most of the tumors had begun to regress, and by day 37 all of the tumors had either regressed or been destroyed. Professor Cui said, "The anti-cancer action of the plasmid seemed to be two-fold. Firstly accumulation of dsRNA resulted in cell death and secondly the presence of dsRNA, and the foreign, unmethylated, plasmid DNA, inside a cell activated both innate and adaptive immune responses."

Professor Cui continued, "In our study both highly immunogenic and poorly immunogenic tumors were receptive to treatment with an RNA replicase based plasmid. Our results suggested a novel approach to cancer molecular therapy."


'/>"/>

Contact: Dr. Hilary Glover
hilary.glover@biomedcentral.com
44-020-319-22370
BioMed Central
Source:Eurekalert

Page: 1

Related biology news :

1. BUSM faculty author commentary on the global challenges of emerging viral infections
2. Therapeutic AIDS vaccine designed by HIVACAT reduces the viral load in the majority of AIDS patients
3. New research aims to shut down viral assembly line
4. Mayo researchers describe measles viral protein movement
5. Viral evasion gene reveals new targets for eliminating chronic infections
6. Unconventional idea for antiviral contraceptive gel wins Gates Foundation grant
7. Chimerix Antiviral CMX001 Inhibits JC Virus Replication in Preclinical Study; Late-Breaker Presented at Antiviral Congress 2010
8. Intriguing viral link to intestinal cancer in mice
9. Texas Tech researcher: Bee colony collapse associated with viral, fungal infection
10. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors
11. Exciting new avenues of research and policy drive expansion of HIV treatment access, use of antiretrovirals to prevent infections and pursuit of a cure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... FRANCISCO , Feb. 13, 2017  RSA ... centralized platform that is designed to enhance fraud ... latest release in the RSA Fraud & Risk ... enable organizations to leverage additional insights from internal ... tools to better protect their customers from targeted ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):
(Date:2/20/2017)... 20, 2017  At the 2017 Health Information ... Orlando , IBM (NYSE: IBM ) ... IBM Chairman, President and CEO Ginni Rometty ... today from 8:30-10 am ET, broadcast live on ... Her remarks examine the advent of the Cognitive ...
(Date:2/18/2017)... Arlington Heights, IL (PRWEB) , ... February 17, ... ... Society for Blood and Marrow Transplantation (ASBMT) and the Center for International Blood ... Gaylord Palms Convention Center in Orlando, Fla. , The combined scientific ...
(Date:2/17/2017)... , Feb. 17, 2017  BioGenex, a global ... development of a novel system for quantitative immunohistochemistry ... the University of Rochester (NY, USA) and Konica-Minolta ... new system is able to accurately quantify the ... (Human epidermal growth factor receptor-2) in clinical samples. ...
(Date:2/16/2017)... ... ... EIT Digital has launched work to develop a new Smart ... about to get under way for the framework, which is designed to reduce the ... expected to be transferred eventually to other industries that also require efficient IoT and ...
Breaking Biology Technology: